The authors investigated the consecutive change of retinal vessel's diameter in affected eye and fellow eye of Branch Retinal Vein Occlusion.
Twenty five consecutive patients who had undergone intravitreal bevacizumab injection for Branch Retinal Vein Occlusion with macular edema were included in this study. All subjects were enrolled between April, 2012 and April, 2013 in the Department of Ophthalmology, Kyungpook National University Hospital.
Study Type
OBSERVATIONAL
Enrollment
25
Dong Ho Park
Daegu, Kyungsangpookdo, South Korea
Unoccluded retinal vessel diameter of Branch Retinal Vein Occlusion
To evaluate the change of unoccluded retinal vessel diameter in affected eye of Branch Retinal Vein Occlusion and unaffected fellow eye.
Time frame: 0, 1, 3, and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.